although
metagenom
previous
employ
pathogen
discoveri
cost
complex
prevent
use
practic
frontlin
diagnost
unknown
infecti
diseas
demonstr
util
two
metagenomicsbas
strategi
panvir
microarray
virochip
deep
sequenc
identif
character
pandem
influenza
viru
use
nasopharyng
swab
collect
earliest
stage
pandem
mexico
canada
unit
state
n
virochip
abl
detect
novel
viru
close
relat
swine
influenza
virus
without
priori
inform
deep
sequenc
yield
read
correspond
influenza
sampl
percentag
align
sequenc
correspond
rang
coverag
influenza
genom
one
sampl
detect
deep
sequenc
possibl
even
titer
near
limit
detect
specif
rtpcr
percentag
sequenc
read
linearli
correl
viru
titer
deep
sequenc
also
provid
insight
upper
respiratori
microbiota
host
gene
express
respons
infect
unbias
analysi
combin
sequenc
data
outbreak
sampl
reveal
genom
could
assembl
de
novo
without
use
refer
sequenc
includ
assembl
sever
near
fulllength
genom
segment
result
indic
streamlin
metagenom
detect
strategi
potenti
replac
multipl
convent
diagnost
test
requir
investig
outbreak
novel
pathogen
provid
blueprint
comprehens
diagnosi
unexplain
acut
ill
outbreak
clinic
public
health
set
influenza
viru
novel
reassort
viru
compris
genom
segment
origin
swine
avian
human
influenza
strain
initi
identif
swineorigin
cdc
april
novel
viru
rapidli
achiev
sustain
humantohuman
transmiss
worldwid
prompt
declar
level
pandem
rapid
develop
vaccin
august
least
million
case
confirm
death
worldwid
pandem
http
emerg
mark
diagnost
difficulti
hamper
earli
effort
detect
rapid
pointofcar
diagnost
insensit
diagnos
novel
viru
exist
molecular
method
rtpcr
abl
detect
influenza
could
differenti
season
infect
initi
effort
character
viru
reli
tradit
sanger
sequenc
use
pcr
primer
highli
conserv
region
influenza
genom
method
would
like
fail
viru
genet
diverg
clinic
laboratori
test
initi
avail
identifi
high
sensit
specif
viru
may
circul
undetect
human
popul
month
thu
clear
need
introduct
broadrang
viral
detect
methodolog
clinic
public
health
set
deal
emerg
threat
influenza
metagenom
approach
includ
microarray
deep
sequenc
proven
increasingli
success
recent
year
diagnosi
infecti
diseas
novel
viral
pathogen
virochip
panvir
microarray
design
simultan
detect
known
virus
novel
viral
speci
strain
also
detect
basi
conserv
sequenc
homolog
known
virus
demonstr
discoveri
sar
coronaviru
virochip
novel
virus
previous
identifi
virochip
includ
new
clade
rhinovirus
human
cardioviru
associ
respiratori
diarrheal
ill
avian
bornaviru
etiolog
agent
outbreak
proventricular
dilat
diseas
pdd
bird
detect
known
respiratori
virus
virochip
microarray
found
sensit
specif
compar
superior
convent
diagnost
test
deep
sequenc
complementari
approach
capabl
detect
virus
diverg
known
virus
detect
either
pcr
microarray
techniqu
review
de
novo
pyrosequenc
enabl
discoveri
two
novel
arenavirus
arenaviru
associ
fatal
cluster
case
solidorgan
transplant
patient
dandenong
viru
hemorrhag
feverassoci
arenaviru
south
africa
lujo
viru
metagenom
approach
especi
attract
studi
influenza
given
constant
threat
antigen
drift
shift
microarray
rapidli
type
origin
differ
segment
guard
threat
novel
reassort
detect
coinfect
pathogen
pyrosequenc
use
resequenc
microarray
monitor
emerg
mutat
confer
virul
resist
antivir
drug
deep
sequenc
strategi
recent
employ
detect
season
influenza
virus
three
clinic
sampl
well
identifi
quasispeci
singl
autopsi
lung
sampl
analyz
group
earli
case
pandem
unit
state
california
canada
mexico
virochip
deep
sequenc
show
virochip
absenc
priori
inform
capabl
rapid
character
influenza
viru
close
relat
swine
influenza
virus
also
demonstr
util
deep
sequenc
clinic
sampl
identifi
character
novel
pathogen
also
microbiota
host
respons
infect
nasopharyng
swab
sampl
collect
patient
north
america
april
june
includ
studi
tabl
fig
studi
patient
children
young
adult
male
averag
age
year
rang
year
although
major
case
upper
respiratori
infect
outpati
set
patient
hospit
presum
infect
three
studi
patient
california
hospit
intens
care
unit
icu
pneumonia
two
three
california
patient
pregnant
women
group
previous
report
high
risk
sever
complic
infect
determin
whether
panvir
microarray
assay
capabl
identifi
novel
absenc
priori
sequenc
inform
use
virochip
comprehens
screen
virus
nasopharyng
swab
sampl
individu
influenzalik
ill
seventeen
sampl
mexico
n
canada
n
unit
state
california
n
suspect
pcrconfirm
case
infect
remain
control
sampl
california
posit
season
influenza
n
season
influenza
n
anoth
respiratori
viru
n
neg
diagnost
test
n
note
probe
virochip
design
prior
emerg
pandem
virochip
hybrid
pattern
correspond
sampl
suspect
confirm
posit
group
togeth
hierarch
cluster
analysi
clearli
distinguish
pattern
correspond
season
influenza
viru
fig
two
sampl
exhibit
weak
microarray
probe
intens
virochip
analysi
group
neg
control
sampl
find
weak
virochip
intens
two
sampl
reproduc
like
secondari
low
viral
titer
andor
high
background
host
nucleic
acid
interfer
random
pcr
amplif
step
virochip
analysi
averag
normal
microarray
intens
sampl
pronounc
probe
deriv
swine
influenza
probe
deriv
human
influenza
ahumanpuerto
differ
statist
signific
sampl
ttest
analysi
fig
microarray
correspond
season
influenza
display
opposit
pattern
probe
deriv
human
influenza
stronger
intens
deriv
swine
influenza
minim
crosshybrid
influenza
probe
observ
sampl
either
neg
harbor
respiratori
virus
virochip
microarray
also
analyz
use
zscore
analysi
epredict
autom
method
viral
speci
identif
microarray
method
incorpor
inform
oligonucleotid
probe
virochip
simultan
includ
probe
full
rang
influenza
strain
reveal
viru
similar
swine
influenza
present
sampl
data
shown
thu
virochip
detect
presenc
viru
close
relat
swine
influenza
sampl
individu
infect
character
metagenom
infect
human
label
influenza
sampl
posit
virochip
distinct
molecular
barcod
analyz
pairedend
deep
sequenc
three
lane
illumina
genom
analyz
iix
trim
read
remov
barcod
exclud
lowcomplex
primer
sequenc
highqual
sequenc
read
subject
iter
blastn
analysi
pipelin
fig
initi
set
read
total
read
align
word
size
evalu
sequenc
obtain
ncbi
nonredund
nucleotid
nt
databas
march
build
distribut
read
align
human
bacteri
viral
sequenc
vari
greatli
depend
upon
laboratori
prepar
method
clinic
sampl
prior
sequenc
figur
sampl
mexico
treat
dnase
postextract
result
read
sampl
align
human
genom
dna
contrast
sampl
treat
dnase
postextract
unit
state
canada
contain
mani
read
align
abund
noncod
rna
includ
human
bacteri
ribosom
rna
rrna
despit
dnase
treatment
read
align
human
mitochondri
genom
remain
abund
sever
sampl
overal
percentag
bacteri
viral
nonalign
read
low
notabl
individu
except
approxim
read
sampl
align
bacteri
sequenc
mostli
correspond
streptococcu
genu
two
sampl
british
columbia
disproportion
larg
number
read
align
virus
due
addit
phage
intern
posit
control
luminex
respiratori
viru
panel
rvp
assay
luminex
austin
tx
determin
alter
upper
respiratori
tract
microbiom
present
sampl
patient
infect
viru
analyz
deep
sequenc
read
align
bacteria
interestingli
bacteri
read
align
rrna
sequenc
like
due
high
rel
abund
rrna
transcript
bacteria
bacteri
mrna
read
observ
given
high
degre
conserv
rrna
sequenc
bacteria
read
could
unambigu
classifi
genu
level
famili
level
case
enterobactericea
fig
gener
high
level
divers
bacteri
famili
observ
differ
sampl
reflect
known
divers
bacteri
flora
nasopharynx
read
top
three
bacteri
famili
compris
anywher
bacteri
read
depend
sampl
fig
moraxellacea
enterobactericea
common
bacteri
famili
found
account
one
three
common
bacteri
famili
sampl
fig
signific
number
read
align
streptococcu
genu
seen
sampl
read
uncultur
agent
environment
sampl
account
sequenc
align
bacteria
major
viral
read
n
align
member
orthomyxovirida
influenza
famili
tabl
phage
compris
second
common
group
virus
includ
known
control
eg
control
phage
trace
reagent
contamin
eg
bacteriophag
environment
phage
read
align
plant
virus
observ
two
sampl
sixteen
read
murin
leukemia
virus
mlv
detect
sampl
gener
mlv
read
align
slightli
better
moloney
murin
leukemia
viru
mmlv
recent
describ
human
xenotrop
murin
leukemiarel
viru
xmrv
although
read
align
ident
interestingli
singl
overlap
pairedend
read
align
ident
filoviru
ebolasudan
queri
coverag
evalu
map
gene
code
ebola
viral
glycoprotein
read
also
align
filovirus
ident
align
viral
famili
abl
reproduc
detect
singl
filoviru
read
specif
rtpcr
despit
use
multipl
set
primer
unabl
recov
addit
filoviru
sequenc
sampl
data
shown
asid
influenza
respiratori
viral
pathogen
detect
human
adenoviru
one
canadian
sampl
read
influenza
read
align
orthomyxovirida
found
specimen
rang
read
align
read
stratifi
origin
locat
correspond
method
sampl
process
prednas
andor
postdnas
treatment
percentag
total
read
align
influenza
linearli
correl
calcul
viral
titer
realtim
quantit
rtpcr
site
unit
state
california
canada
mexico
fig
treatment
dnase
twice
yield
best
percentag
recoveri
howev
despit
low
viral
titer
influenza
still
detect
deep
sequenc
read
align
influenza
respect
tabl
influenza
read
segment
found
sampl
read
least
two
differ
segment
found
everi
sampl
fig
fig
interestingli
read
ns
nonstructur
segment
significantli
less
like
found
read
segment
chisquar
analysi
ns
read
detect
sampl
contrast
read
found
sampl
sampl
mexico
worst
overal
coverag
like
due
high
percentag
human
genom
background
sequenc
result
treat
sampl
dnase
postextract
sampl
best
overal
coverag
genom
least
coverag
genom
least
coverag
sought
assess
accuraci
deep
sequenc
rel
tradit
sanger
sequenc
well
search
singl
nucleotid
polymorph
snp
assembl
deep
sequenc
read
may
repres
heterogen
popul
influenza
deep
sequenc
read
two
sampl
studi
highest
coverag
genom
coverag
coverag
map
fullgenom
scaffold
obtain
sanger
sequenc
overal
high
degre
concord
deep
sequenc
tradit
sanger
sequenc
tabl
next
identifi
potenti
mutat
key
site
genom
mediat
drug
resist
virul
compar
genom
fullgenom
refer
sequenc
tabl
total
nonambigu
nucleotid
differ
origin
california
strain
nonambigu
nucleotid
differ
origin
strain
detect
sanger
sequenc
deep
sequenc
alon
respect
nucleotid
differ
correspond
nonsynonym
mutat
genom
respect
genom
segment
amino
acid
chang
ha
gene
nucleotid
differ
differ
refer
sequenc
key
site
genom
correspond
known
mutat
antivir
resist
enhanc
transmiss
increas
virul
databas
sampl
consid
aris
mrna
transcript
sinc
rnaseq
data
correspond
nasopharyng
sampl
healthi
individu
found
ncbi
sequenc
read
archiv
http
wwwncbinlminhgovsra
use
set
nasopharyng
swab
sampl
collect
kleinelevin
syndrom
kl
patient
influenzalik
ill
test
neg
influenza
background
control
gene
associ
immun
interferon
significantli
upregul
four
influenza
sampl
compar
control
sampl
two
studi
site
differ
specimen
process
protocol
fig
interferonrel
gene
preferenti
upregul
sampl
rel
control
code
chemokin
ligand
oligoadenyl
synthetas
ifninduc
protein
stat
protein
protein
previous
shown
play
essenti
role
interferonmedi
host
immun
respons
viral
infect
upregul
interferon
immun
gene
seen
four
sampl
highest
coverag
influenza
genom
necessarili
sampl
high
number
total
transcriptom
read
fig
gene
associ
cell
structur
motil
well
protein
metabol
intracellular
protein
traffick
also
upregul
sampl
rel
control
sampl
fig
hypothes
unpreced
depth
coverag
obtain
deep
sequenc
could
enabl
detect
even
de
novo
assembl
novel
viral
pathogen
absenc
refer
genom
demonstr
feasibl
approach
elucid
caus
outbreak
hitherto
novel
unknown
virus
gener
modifi
nt
databas
sequenc
correspond
orthomyxovirida
famili
remov
fig
pure
de
novo
assembl
pairedend
read
pool
sampl
align
modifi
nt
databas
construct
use
geneiou
softwar
geneiou
auckland
nz
final
contig
contigu
sequenc
length
greater
bp
gener
de
novo
assembl
contig
map
onto
refer
sequenc
influenza
contig
size
bp
coverag
genom
fig
four
longest
contig
correspond
includ
nearli
fulllength
sequenc
polymeras
np
nucleoprotein
na
neuraminidas
segment
fig
cursori
analysi
remain
contig
map
influenza
genom
reveal
sequenc
lowcomplex
sequenc
artifact
similar
analysi
perform
best
singl
sampl
de
novo
assembl
genom
possibl
misassembl
observ
even
though
percentag
orthomyxovirida
read
sampl
alon
compris
correspond
unalign
read
modifi
nt
databas
respect
studi
demonstr
util
metagenomicsbas
strategi
combin
rapid
broadspectrum
diagnost
assay
virochip
microarray
comprehens
deep
sequenc
identifi
character
novel
outbreak
pathogen
use
pandem
influenza
case
exampl
virochip
capabl
differenti
season
influenza
novel
pandem
strain
use
multipl
probe
design
priori
accur
character
novel
viru
close
relat
swine
influenza
virus
complementari
deep
sequenc
clinic
sampl
collect
earli
cours
pandem
enabl
detect
read
novel
strain
everi
sampl
well
de
novo
assembl
genom
amidst
enorm
background
unalign
sequenc
read
sar
coronaviru
lack
broadbas
diagnost
test
suffici
sensit
specif
like
contribut
delay
identif
caus
initi
outbreak
influenzalik
ill
mexico
approach
use
virochip
microarray
rapid
screen
deep
sequenc
de
novo
assembl
detail
character
robust
comprehens
directli
applic
investig
futur
outbreak
novel
viral
pathogen
especi
grow
cultur
nearli
previou
studi
metagenom
sequenc
virus
human
clinic
materi
detect
discoveri
employ
pyrosequenc
longer
read
pyrosequenc
bp
facilit
assembl
individu
read
contig
assist
classif
read
homologybas
blast
align
result
suggest
exampl
longerread
sequenc
method
pyrosequenc
may
better
suit
illumina
sequenc
identif
bacteria
accur
discrimin
bacteria
speci
even
genu
level
possibl
short
illumina
read
fig
rrna
sequenc
correspond
relat
bacteria
found
essenti
ident
rang
de
novo
assembl
short
illumina
read
align
bacteri
rrna
longer
easili
identifi
contig
given
known
presenc
multipl
relat
bacteri
speci
nasopharynx
high
like
risk
produc
misassembl
hand
key
advantag
illumina
sequenc
signific
increas
read
depth
rel
pyrosequenc
greater
depth
sequenc
provid
better
accur
genom
coverag
well
increas
capabl
multiplex
clinic
sampl
studi
influenza
deep
sequenc
illumina
read
length
bp
suffici
long
accur
classifi
vast
major
individu
read
thu
make
de
novo
contig
assembl
prior
align
unnecessari
addit
limit
comput
resourc
requir
de
novo
assembl
million
sequenc
reason
amount
time
result
demonstr
comput
pipelin
consist
sequenti
align
individu
read
use
highstring
cutoff
fig
follow
de
novo
assembl
remain
unalign
read
detail
analysi
result
contig
fig
effici
strategi
analyz
larg
dataset
gener
illumina
sequenc
clinic
sampl
pathogen
discoveri
particular
final
de
novo
assembl
step
critic
identifi
diverg
sequenc
may
correspond
novel
pathogen
assembl
longer
contig
also
eas
burden
comput
intens
amino
acid
comparison
algorithm
blastx
tblastx
phiblast
reduc
number
sequenc
need
analyz
although
cost
deep
sequenc
usd
sampl
still
much
greater
reagent
cost
diagnost
rtpcr
assay
usd
deep
sequenc
abl
gener
much
use
inform
includ
data
microbiom
host
gene
express
well
wholegenom
sequenc
pathogen
would
requir
exampl
least
usd
per
influenza
genom
via
tradit
method
addit
unbias
deep
sequenc
allow
broadbas
detect
novel
virus
may
elud
diagnosi
specif
rtpcr
assay
pairedend
read
length
achiev
illumina
platform
approach
bp
use
deep
sequenc
identif
even
highli
diverg
pathogen
exceedingli
low
titer
becom
feasibl
number
read
correspond
abil
map
sequenc
onto
genom
highli
depend
method
sampl
prepar
fewest
viral
read
detect
five
sampl
mexico
treat
dnase
nucleic
acid
extract
sampl
contain
highest
percentag
human
genom
sequenc
sequenc
align
human
genom
well
fewest
read
bacteria
nakamura
et
al
also
found
host
genom
materi
nasopharyng
aspir
influenzainfect
individu
detect
similarli
low
percentag
read
influenza
despit
use
centrifug
remov
bacteri
cellular
materi
data
indic
one
import
step
viral
detect
deep
sequenc
may
remov
host
genom
dna
postextract
treatment
dnase
rel
straightforward
procedur
clinic
laboratori
postextract
dnase
treatment
effici
observ
residu
dna
mitochondri
read
sever
sampl
true
addit
preprocess
filtrat
ultracentrifug
densitygradi
purif
would
like
result
even
better
enrich
viral
sequenc
howev
metagenom
studi
sought
mimic
close
possibl
clinicalpubl
health
laboratori
set
enrich
strategi
may
laborintens
neither
conduc
demand
clinic
laboratori
practic
given
limit
amount
clinic
sampl
avail
addit
import
drawback
direct
viral
purif
method
bias
sampl
toward
viru
detect
sever
hinder
abil
detect
potenti
nonvir
pathogen
investig
pattern
human
gene
express
respons
viral
infect
done
suggest
coinfect
streptococcu
pneumonia
may
impact
sever
clinic
present
patient
infect
remark
copathogen
either
viral
bacteri
found
among
sampl
chosen
analysi
deep
sequenc
reveal
five
sampl
signific
number
bacteri
read
streptococcu
genu
may
either
repres
potenti
pathogen
eg
streptococcu
pneumonia
simpli
normal
human
nasopharyng
viral
flora
eg
streptococcu
orali
sangui
andor
miti
one
sampl
canadian
patient
upper
respiratori
infect
contain
small
number
read
adenoviru
type
n
result
impli
copathogen
play
signific
role
infect
influenza
sampl
analyz
studi
much
larger
sampl
set
need
fulli
ascertain
role
copathogen
infect
although
sampl
contain
read
murin
leukemia
virus
appear
probabl
basi
sequenc
align
sourc
read
trace
mmlv
vector
contamin
revers
transcriptas
enzym
use
prepar
librari
deep
sequenc
rather
infect
xmrv
gammaretroviru
associ
prostat
cancer
chronic
fatigu
syndrom
human
recent
detect
respiratori
tract
addit
one
sampl
contain
pairedend
read
nt
match
filoviru
ebolasudan
consid
like
laboratori
contamin
sinc
identifi
read
filovirus
unabl
amplifi
addit
filoviru
sequenc
howev
origin
sequenc
ultim
remain
unknown
could
subsequ
detect
sampl
reagent
specif
rtpcr
none
laboratori
involv
analysi
work
ebola
viru
also
found
read
correspond
plant
virus
two
sampl
detect
plant
virus
nasal
swab
sampl
unexpect
given
nasopharynx
contigu
oropharynx
abund
plant
virus
presum
dietari
origin
found
human
digest
tract
discoveri
unexpect
viral
read
correspond
murin
leukemia
virus
filovirus
plant
virus
deep
sequenc
data
underscor
challeng
analyz
rare
uniqu
sequenc
may
correspond
colon
flora
reagentsampl
contamin
even
true
pathogen
use
deep
sequenc
abl
recov
assembl
near
fulllength
genom
sequenc
viru
two
individu
patient
specimen
sinc
molecular
determin
influenza
pathogenesi
wellstudi
abl
analyz
genom
sequenc
singl
nucleotid
polymorph
snp
specif
correl
antivir
resist
enhanc
transmiss
increas
virul
novel
viru
genotyp
find
would
yet
correl
phenotyp
data
overal
sequenc
structur
genom
may
still
yield
valuabl
insight
viral
transmiss
mechan
pathogenesi
analysi
transcriptom
read
demonstr
immun
interferon
gene
significantli
upregul
nasopharyng
swab
sampl
patient
compar
background
control
interestingli
sampl
necessarili
high
number
transcriptom
read
highest
coverag
influenza
genom
fig
coverag
influenza
genom
may
best
proxi
measur
influenza
activ
associ
host
respons
deep
sequenc
analysi
rel
independ
pcr
duplic
artifact
introduc
sampl
prepar
deep
sequenc
find
increas
express
interferonassoci
host
gene
clinic
sampl
patient
infect
intrigu
consist
recent
data
show
protein
lack
abil
block
gener
host
gene
express
human
swine
cell
vitro
studi
need
assess
clinic
relev
increas
interferonassoci
host
gene
express
infect
vivo
nevertheless
find
highlight
power
unbias
deep
sequenc
approach
facilit
detect
viral
pathogen
also
enabl
element
host
respons
simultan
interrog
thu
gener
new
hypothes
analysi
hostpathogen
interact
studi
first
explor
relationship
viral
titer
depth
sequenc
requir
detect
candid
viral
pathogen
sampl
treat
dnase
nucleic
acid
extract
postdnas
linear
correl
percentag
viral
read
deep
sequenc
data
viral
titer
estim
quantit
rtpcr
fig
observ
correl
sampl
undergo
postdnas
treatment
like
secondari
high
residu
host
genom
background
thu
find
may
appli
rna
viral
target
howev
encourag
sequenc
read
correspond
detect
sampl
even
sampl
low
viral
titer
approach
analyt
limit
detect
rtpcr
assay
ie
fig
studi
clearli
need
metagenom
differ
viral
agent
eg
rna
vs
dna
virus
lysogen
vs
lytic
etc
across
differ
stage
infect
eg
presymptomat
acut
chronic
differ
type
clinic
sampl
eg
respiratori
secret
stool
blood
cerebrospin
fluid
tissu
etc
addit
although
virochip
microarray
hour
turnaround
time
rapidli
deploy
comprehens
screen
viral
pathogen
set
outbreak
complementari
deep
sequenc
approach
current
limit
time
necessari
perform
full
pairedend
sequenc
run
illumina
genet
analyz
iix
week
analyz
data
highli
parallel
comput
platform
run
core
simultan
week
nevertheless
data
obtain
day
week
microarray
deep
sequenc
would
take
month
year
use
convent
method
furthermor
thirdgener
sequenc
technolog
gener
deep
sequenc
data
within
hour
avail
result
describ
provid
blueprint
eventu
use
microarray
sequenc
routin
diagnost
tool
pathogen
clinic
public
health
laboratori
case
influenzalik
ill
canada
mexico
confirm
suspect
posit
infect
identifi
individu
state
public
health
agenc
inform
consent
obtain
analysi
sampl
pathogen
part
mandat
clinic
test
individu
agenc
sampl
well
demograph
clinic
laboratori
data
deidentifi
prior
analysi
case
california
enrol
viral
diagnost
studi
approv
univers
california
san
francisco
ucsf
institut
review
board
irb
protocol
written
inform
consent
obtain
studi
particip
andor
legal
guardian
case
collect
sampl
analyz
protocol
approv
ucsf
irb
protocol
case
influenzalik
ill
canada
mexico
report
provid
hospit
british
columbia
centr
diseas
control
bccdc
univers
toronto
ontario
agenc
health
protect
promot
oahpp
veracruz
ministri
health
suspect
confirm
case
identifi
routin
laboratori
surveil
protocol
approv
individu
state
public
health
agenc
case
nonidentifi
demograph
clinic
data
report
standard
form
case
california
identifi
infecti
diseas
physician
univers
california
san
francisco
ucsf
demographicclin
data
abstract
medic
record
nasopharyng
swab
sampl
collect
viral
transport
media
patient
either
laboratoryconfirm
suspect
case
influenza
viru
analyz
twelv
addit
nasopharyng
swab
sampl
california
includ
neg
control
virochip
rna
extract
perform
differ
use
establish
protocol
specif
individu
laboratori
mexico
ml
sampl
linear
polyacrylamid
ambion
inc
austin
tx
ad
rna
carrier
treat
turbo
dnase
ambion
inc
austin
tx
minut
prednas
treatment
nucleic
acid
extract
use
purelink
rnadna
kit
invitrogen
carlsbad
ca
accord
manufactur
instruct
british
columbia
ontario
ml
ml
respect
sampl
extract
use
nuclisen
easymag
autom
extract
system
treat
turbo
dnase
postdnas
treatment
california
ml
sampl
treat
turbo
dnase
nucleic
acid
extract
zymo
viral
rna
kit
zymo
research
orang
ca
extract
nucleic
acid
treat
turbo
dnase
prepostdnas
treatment
total
rna
reversetranscrib
cdna
amplifi
modifi
round
ab
random
pcr
method
label
fluoresc
dye
previous
describ
label
sampl
normal
pmol
incorpor
dye
hybrid
overnight
use
agil
gene
express
hybrid
kit
accord
manufactur
protocol
agil
technolog
santa
clara
california
microarray
slide
use
customdesign
array
synthes
agil
technolog
contain
virochip
oligonucleotid
probe
common
common
probe
includ
conserv
well
specif
probe
repres
viral
speci
genbank
deriv
previou
virochip
design
virochip
yet
commerci
avail
current
implement
core
diagnost
servic
ucsf
viral
diagnost
discoveri
center
http
vddcucsfedu
slide
scan
mm
resolut
xdr
extend
dynam
rang
mode
use
agil
dna
microarray
scanner
virochip
microarray
analyz
hierarch
cluster
analysi
epredict
zscore
singl
oligonucleotid
analysi
previous
describ
averag
normal
microarray
intens
analyz
use
twosampl
twotail
ttest
unequ
varianc
virochip
microarray
use
studi
submit
ncbi
geo
databas
studi
access
number
microarray
access
number
microarray
design
access
number
array
array
sequenc
correspond
influenza
segment
obtain
onestep
rtpcr
use
either
qiagen
onestep
rtpcr
kit
qiagen
valencia
ca
invitrogen
superscriptiii
onestep
rtpcr
kit
high
fidel
platinum
taq
invitrogen
carlsbad
ca
primer
design
base
conserv
termin
central
region
segment
tabl
reaction
run
qiagen
kit
done
duplic
account
potenti
polymeras
error
pcr
product
run
agaros
gel
band
correct
size
cut
extract
fragment
clone
vector
invitrogen
carlsbad
ca
sanger
sequenc
elim
biopharmaceut
hayward
ca
primer
well
origin
conserv
pcr
primer
least
threefold
redund
obtain
segment
wholegenom
sequenc
sampl
includ
segment
submit
genbank
genbank
access
number
quantit
rtpcr
influenza
perform
primer
base
conserv
region
ha
segment
use
stratagen
realtim
pcr
system
pcr
perform
use
qiagen
onestep
rtpcr
kit
qiagen
valencia
ca
ml
reaction
contain
ml
h
ml
pcr
buffer
ml
q
solut
ml
dntp
ml
rttaq
enzym
mix
ml
primer
ml
sybr
green
ml
total
rna
condit
pcr
min
min
cycl
min
final
extens
min
viral
titer
estim
use
standard
curv
deriv
vitrotranscrib
quantifi
influenza
mrna
standard
data
shown
canadian
sampl
viral
titer
determin
ct
valu
compar
realtim
rtpcr
data
obtain
independ
refer
laboratori
vancouv
bccdc
toronto
oahpp
check
accuraci
data
shown
librari
deep
sequenc
prepar
amplifi
cdna
librari
use
previous
publish
protocol
briefli
librari
cleav
type
ii
restrict
endonucleas
gsui
truncat
adapt
contain
uniqu
bp
molecular
barcod
ligat
result
strand
end
fulllength
adapt
subsequ
ad
via
addit
cycl
pcr
librari
sizeselect
polyacrylamid
gel
approxim
bp
averag
length
load
final
concentr
pm
three
lane
secondgener
genom
analyz
iix
illumina
san
diego
ca
pairedend
read
sequenc
cycl
direct
fluoresc
imag
analyz
use
illumina
basecal
pipelin
obtain
pairedend
sequenc
data
pairedend
read
subsequ
classifi
strict
barcod
filter
elimin
lowcomplex
sequenc
lzw
compress
ratio
cutoff
split
individu
read
strip
remain
primer
sequenc
use
blastn
align
word
size
evalu
blastn
align
publicli
avail
sequenc
databas
perform
use
four
extralarg
high
cpuinstanc
amazon
elast
cloud
comput
server
compris
total
core
processor
approxim
comput
time
hour
per
sequenc
lane
sequenc
read
align
human
rrna
mitochondri
genom
blastn
word
size
evalu
initi
remov
remain
read
classifi
success
blastn
align
refseq
human
transcriptom
databas
word
size
evalu
septemb
build
releas
ncbi
nonredund
nucleotid
nt
databas
word
size
evalu
march
build
read
align
nt
sort
best
hit
respect
taxa
analysi
read
align
nt
align
human
bacteri
viral
sequenc
categor
consist
sole
environment
sequenc
plasmidsartifici
construct
presenc
murin
leukemia
viru
ebola
viru
deep
sequenc
librari
independ
confirm
specif
rtpcr
direct
sequenc
data
shown
also
separ
perform
direct
blastn
align
origin
set
unclassifi
deep
sequenc
read
influenza
sequenc
databas
word
size
evalu
verifi
influenza
read
incorrectli
classifi
human
nonvir
sequenc
data
shown
highqual
sequenc
read
submit
ncbi
sequenc
read
archiv
http
wwwncbinlmnihgovsra
access
number
read
correspond
human
mrna
transcriptom
count
gene
compar
transcriptom
read
nasopharyng
swab
sampl
kleinelevin
syndrom
kl
patient
influenzalik
ill
kl
neuropsycholog
disord
mark
hypersomnol
hyperphagia
hypersexu
usual
found
adolesc
boy
ongo
metagenom
analysi
sampl
patient
kl
kl
sampl
deep
sequenc
found
read
singl
rhinoviru
isol
one
sampl
read
influenza
sampl
addit
kl
sampl
neg
pandem
season
influenza
specif
rtpcr
data
shown
thought
kl
sampl
could
serv
appropri
background
control
individu
influenzalik
ill
test
neg
influenza
purpos
transcriptom
analysi
particular
kl
sampl
deriv
similar
demograph
sampl
children
young
adult
process
ident
deep
sequenc
transcriptom
analysi
perform
follow
first
select
gene
refseq
significantli
overexpress
nasopharyng
swab
sampl
rel
kl
background
sampl
bonferronicorrect
fisher
exact
test
identifi
overrepres
categori
gene
input
overexpress
refseq
gene
panther
protein
analysi
evolutionari
relat
databas
http
pantherappliedbiosystemscom
compar
human
refer
list
transcrib
gene
categori
gene
significantli
upregul
influenza
data
rel
human
refer
list
bonferronicorrect
fisher
exact
test
report
snp
analysi
sequenc
read
map
influenza
perform
use
softwar
packag
pairedend
read
inform
fastqformat
qualiti
score
incorpor
call
snp
snp
call
perform
high
stringenc
ensur
accuraci
specif
illumina
deep
sequenc
data
calcul
overal
error
rate
analysi
phix
control
lane
illumina
inc
hayward
ca
least
coverag
qualiti
score
requir
map
deep
sequenc
read
given
posit
genom
minor
snp
defin
present
occur
time
given
nucleotid
posit
pairedend
de
novo
assembl
influenza
genom
perform
use
geneiou
version
softwar
strict
paramet
word
length
mismatchgap
toler
pairedend
read
includ
assembl
expect
pairedend
mate
distanc
avoid
misassembl
de
novo
assembl
algorithm
use
geneiou
greedi
algorithm
similar
use
multipl
sequenc
align
program
clustalw
matt
kears
geneiou
inc
person
commun
initi
gener
contig
size
bp
assembl
de
novo
geneiou
high
sensit
fine
tune
gap
trim
contig
end
final
de
novo
assembl
contig
map
fullgenom
refer
sequenc
genbank
access
number
remain
contig
map
influenza
contig
correspond
lowcomplex
sequenc
identifi
appli
lzw
compress
ratio
slightli
higher
use
initi
filter
